SuperworthCorteva CTVA
- Market cap
- $8.3B
- PE
- 8.2×
- 6y median 36.7×
- Forward PE
- 156×
- 7y median 24.1×
- Price to sales
- 0.5×
- EV/EBIT
- 6.4×
- Revenue, 12 months
- $17.8B
- +4% on a year ago
- Net margin
- 5.7%
- Free cash flow yield
- 7.6%
Corteva trades at 8.2× trailing earnings, cheaper than 100% of the last ten years. Revenue was $17.8B over the last twelve months, up 4% on a year earlier with a 6% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.6B−7% | $3.7B−3% | $4.5B−8% | $6.1B+1% | $2.3B−10% | $4B+7% | $4.4B−2% | $6.5B+6% | $2.6B+13% | $3.9B−2% | $4.9B+11% | $6.4B−1% | |
| Cost of revenue | $1.6B−12% | $2.4B−6% | $2.5B−8% | $2.9B−7% | $1.6B−5% | $2.5B+6% | $2.3B−8% | $2.9B+1% | $1.6B+5% | $2.3B−10% | $2.4B+1% | $2.7B−7% |
| Gross profit | $944M+5% | $1.3B+2% | $1.9B−8% | $3.2B+10% | $761M−19% | $1.5B+11% | $2.1B+7% | $3.5B+10% | $974M+28% | $1.7B+12% | $2.5B+22% | $3.7B+4% |
| R&D | $335M+7% | $357M+5% | $332M+5% | $357M+9% | $348M+4% | $365M+2% | $335M+1% | $375M+5% | $351M+1% | $413M+13% | $341M+2% | $388M+4% |
| SG&A | $670M+2% | $735M−4% | $736M+1% | $1.1B+1% | $671M+0% | $735M+0% | $751M+2% | $1.2B+10% | $725M+8% | $860M+17% | $877M+17% | $1.2B+1% |
| −$237M−41% | −$167M+828% | $622M−29% | $1.5B+17% | −$526M+122% | $129M | $805M+29% | $1.8B+16% | −$347M−34% | $181M+40% | $1B+26% | $1.8B+2% | |
| Interest expense | $58M+222% | $62M+72% | $41M+32% | $66M−20% | $66M+14% | $60M−3% | $36M−12% | $52M−21% | $46M−30% | $46M−23% | $36M+0% | $47M−10% |
| Pre-tax income | −$444M+12% | −$323M+59% | $482M−38% | $1.3B+23% | −$633M+43% | $88M | $784M+63% | $1.8B+35% | −$370M−42% | −$530M | $858M+9% | $1.6B−10% |
| −$129M+74% | −$92M−43% | $106M−37% | $282M+38% | −$114M−12% | $138M | $117M+10% | $422M+50% | −$62M−46% | $7M−95% | $133M+14% | $408M−3% | |
| Net income | −$321M−3% | −$253M+360% | $419M−30% | $1.1B+48% | −$524M+63% | −$41M−84% | $652M+56% | $1.3B+25% | −$320M−39% | −$552M+1246% | $720M+10% | $1.2B−12% |
| −$0.45−2% | −$0.36+350% | $0.60−28% | $1.51+51% | −$0.76+69% | −$0.06−83% | $0.95+58% | $1.92+27% | −$0.47−38% | −$0.82+1267% | $1.07+13% | $1.73−10% | |
| 708.4M−1% | 704M−2% | 702.8M−2% | 698.1M−2% | 691.1M−2% | 687.4M−2% | 686.6M−2% | 683.1M−2% | 678.7M−2% | 675M−2% | 673.6M−2% | 669.8M−2% |
Gross profit: 34 periods, Q1 FY18 to Q2 FY26: not printed by the filing, worked out from its own lines.
Operating income: 23 periods, Q1 FY18 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 8 periods, Q1 FY18 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY18: share-days: the 6-month average less the second quarter's. 5 periods, Q4 FY19 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY20 and Q4 FY21: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $1.8B | $1.7B to $1.8B | $0.02 | $0.02 to $0.02 | 5 |
| Q4 FY26 | $2.3B | $2.3B to $2.3B | $0.08 | $0.06 to $0.12 | 4 |
| Q1 FY27 | $1.9B | $1.9B to $2B | $0.15 | $0.15 to $0.15 | 1 |
| Q2 FY27 | $1.9B | $1.9B to $1.9B | $0.15 | $0.15 to $0.15 | 1 |
| Q3 FY27 | $1.8B | $1.8B to $1.9B | $0.03 | $0.03 to $0.03 | 1 |
| Q4 FY27 | $2.4B | $2.3B to $2.4B | $0.11 | $0.11 to $0.11 | 1 |
| Q1 FY28 | $5.2B | $5.2B to $5.3B | $0.24 | $0.24 to $0.25 | 2 |
| Q2 FY28 | $6.9B | $6.9B to $7B | $0.43 | $0.42 to $0.43 | 2 |
Peers
Companies in Agricultural Inputs nearest Corteva's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CTVACorteva | $8.3B | 8.2× | 36.7× | 156× | 0.5× | +4% | 5.7% |
| CFCF Industries | $18.3B | 8.9× | 14.0× | n/m | 2.4× | +20% | 27.1% |
| SMGScotts Miracle-Gro | $3.5B | 51.1× | 22.7× | n/m | 1.0× | +1% | 2.2% |
| CALMCal-Maine Foods | $2.9B | 53.5× | 11.8× | n/m | 1.2× | −43% | 2.3% |
| DMCDEL Monte | $1.4B | 41.6× | 20.2× | n/m | 0.3× | −0% | 0.8% |
| UANCVR Partners | $1.3B | 8.3× | 9.1× | n/m | 2.0× | +17% | 23.7% |
| AVOMission Produce | $1B | 390× | 37.1× | n/m | 0.8× | −6% | 0.1% |
| Peer median | $2.2B | 46.3× | 17.1× | n/a | 1.1× | +1% | 2.3% |
Investors who own it
Investors we follow who held Corteva at the end of Jun 30, 2026, from their 13F filings.
- Bill NygrenHarris Associates (Oakmark)1.8% of portfoliotrimmed
More on Corteva
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 22Materials stocks with the highest dividend yields
- #6of 106Materials stocks with the lowest EV/EBIT
- #5of 81Materials stocks with the lowest PE ratio
- #1of 11Agricultural Inputs stocks with the lowest EV/EBIT
- #4of 13Agricultural Inputs stocks with the highest profit margins
- #5of 13Agricultural Inputs stocks with the fastest revenue growth
- #9of 19Agricultural Inputs stocks with the lowest price to sales ratio
Its groups
About
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .